Ella Fitszimmons
Sep 10, 2008

Xian Janssen shifts two brands to Bates141

BEIJING - Bates141 has secured the creative duties for two of Johnson & Johnson subsidiary Xian Janssen Pharmaceutical's over-the-counter products, following a pitch contested by two other agencies.

Xian Janssen shifts two brands to Bates141
DMG was the incumbent for Motilium, which has a reported media spend of US$30 million, though it could not be confirmed whether it attempted to defend the account.

Motilium (a stomach motility drug) is currently the most successful OTC medication across categories in China. The second brand, Mylanta, is a new antacid.

Source:
Campaign China

Related Articles

Just Published

1 hour ago

Should brands try to be 'besties' with GenZ?

Pandering to GenZ by ‘meme-jacking’ will not help brands if they do not compensate and credit creators, says Bob Gold & Associates’ Albert Heape

2 hours ago

BBC launches review of $76 million media planning ...

Incumbent Havas Media Network has handled the account ever since 2015.

3 hours ago

The Oscars 2025: Who will win the film poster review?

AML Group creatives Lizzie Hutchison and Stephen O’Neill discuss the highs (and lows) of posters for this year’s Best Picture nominees at the Oscars.

14 hours ago

Ramadan 2025: How Indonesians plan to spend, save, ...

Despite economic jitters, nearly half of Indonesians plan to give more to charity this Ramadan, with mosques remaining the top destination for Zakat donations, according to YouGov.